VeriMomIst resorcinol bis-ethylhexanoate in der Schwangerschaft sicher?
Searches of regulatory and literature databases (ECHA registration/C&L, PubMed, CIR, CosIng, EWG) did not identify a harmonised CLP classification, an EU Annex II/III restriction, SCCS/CIR safety assessment, or peer‑reviewed reproductive/developmental studies for 'resorcinol bis‑(2‑ethylhexanoate)' (or close name variants). In the absence of reproductive or endocrine‑activity data and with no EU ban/restriction, hazard and mechanism are scored 0. Exposure is scored 1 (low but measurable) because the compound is an organic, lipophilic ester (typical cosmetic esters have at least low dermal absorption). Sources searched did not return evidence of reproductive hazard.
Related ingredients
Frequently asked questions
- Ist resorcinol bis-ethylhexanoate in der Schwangerschaft sicher?
- Searches of regulatory and literature databases (ECHA registration/C&L, PubMed, CIR, CosIng, EWG) did not identify a harmonised CLP classification, an EU Annex II/III restriction, SCCS/CIR safety assessment, or peer‑reviewed reproductive/developmental studies for 'resorcinol bis‑(2‑ethylhexanoate)' (or close name variants). In the absence of reproductive or endocrine‑activity data and with no EU ban/restriction, hazard and mechanism are scored 0. Exposure is scored 1 (low but measurable) because the compound is an organic, lipophilic ester (typical cosmetic esters have at least low dermal absorption). Sources searched did not return evidence of reproductive hazard.
- Ist resorcinol bis-ethylhexanoate während des Stillens sicher?
- No evidence found for reproductive or lactation-specific toxicity or mechanistic endocrine activity. By analogy with topical cosmetic esters, low but measurable maternal absorption could allow minimal transfer to breastmilk; therefore exposure scored 1. No authoritative sources (EU Annex, harmonised H‑code, SCCS/CIR) indicate restriction for lactation.
- Ist resorcinol bis-ethylhexanoate sicher für Babyhaut?
- No infant-specific toxicology or clinical safety data were located. Following your rule to increase exposure by +1 for baby skin when the adult exposure is measurable, baby exposure is scored 2 (moderate) because infants have higher surface‑area‑to‑weight and an immature barrier. Hazard and mechanism remain 0 in the absence of data showing reproductive, developmental, or endocrine activity.
- Wie bewertet VeriMom resorcinol bis-ethylhexanoate?
- VeriMom bewertet resorcinol bis-ethylhexanoate mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu resorcinol bis-ethylhexanoate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu resorcinol bis-ethylhexanoate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.